期刊
SLEEP MEDICINE
卷 10, 期 1, 页码 19-25出版社
ELSEVIER
DOI: 10.1016/j.sleep.2008.06.005
关键词
Drug therapy; Respiratory diseases; Sleep disorders; Insomnia; Chronic Obstructive Pulmonary Disease; Hypnotics
Chronic obstructive Pulmonary disease (COPD) is one of the leading causes of mortality and morbidity worldwide. Because of the chronic nature of the disease, optimal care for patients includes successful treatment of comorbidities that accompany COPD, including insomnia. Insomnia symptoms and associated disruption or sleep are prevalent in COPD patients but treatment with traditional benzodiazepines may compromise respiratory function. This review Summarizes the efficacy and safety consideration Of Current drugs available for the treatment of insomnia in COPI) patients including benzodiazepines, non-benzodiazepine receptor agonists such as eszopielone, zolpidem, and zaleplon, sedating antidepressants such as trazodone, and the melatonin receptor agonist ramelteon. (C) 2009 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据